優(yōu)勢供應(yīng),量大從優(yōu),歡迎咨詢
PT2977 is a potential treatment for clear cell renal cell carcinoma (ccRCC). PT2977 is an orally active and selective HIF-2α inhibitor (IC50: 9 nM). PT2977, as a second-generation HIF-2α inhibitor, increases potency and improves pharmacokinetic profile.
開封明仁藥業(yè)有限公司
聯(lián)系商家時請?zhí)峒癱hemicalbook,有助于交易順利完成!